A new trading day began on Friday, with Aquestive Therapeutics Inc (NASDAQ: AQST) stock price up 3.22% from the previous day of trading, before settling in for the closing price of $3.11. AQST’s price has ranged from $2.24 to $5.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.34%. Meanwhile, its annual earnings per share averaged -30.07%. With a float of $87.78 million, this company’s outstanding shares have now reached $91.41 million.
Let’s determine the extent of company efficiency that accounts for 142 employees. In terms of profitability, gross margin is 68.95%, operating margin of -53.46%, and the pretax margin is -76.7%.
Aquestive Therapeutics Inc (AQST) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Aquestive Therapeutics Inc is 11.22%, while institutional ownership is 38.69%. The most recent insider transaction that took place on Nov 26 ’24, was worth 214. In this transaction Chief Operating Officer of this company sold 44 shares at a rate of $4.87, taking the stock ownership to the 0 shares.
Aquestive Therapeutics Inc (AQST) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -30.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.68% during the next five years compared to 27.90% growth over the previous five years of trading.
Aquestive Therapeutics Inc (NASDAQ: AQST) Trading Performance Indicators
Here are Aquestive Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.52, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Aquestive Therapeutics Inc (AQST)
Looking closely at Aquestive Therapeutics Inc (NASDAQ: AQST), its last 5-days average volume was 1.68 million, which is a drop from its year-to-date volume of 1.72 million. As of the previous 9 days, the stock’s Stochastic %D was 89.52%. Additionally, its Average True Range was 0.22.
During the past 100 days, Aquestive Therapeutics Inc’s (AQST) raw stochastic average was set at 22.69%, which indicates a significant decrease from 95.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.57% in the past 14 days, which was higher than the 68.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.98, while its 200-day Moving Average is $3.78. However, in the short run, Aquestive Therapeutics Inc’s stock first resistance to watch stands at $3.30. Second resistance stands at $3.39. The third major resistance level sits at $3.53. If the price goes on to break the first support level at $3.07, it is likely to go to the next support level at $2.92. Now, if the price goes above the second support level, the third support stands at $2.83.
Aquestive Therapeutics Inc (NASDAQ: AQST) Key Stats
With a market capitalization of 317.38 million, the company has a total of 98,871K Shares Outstanding. Currently, annual sales are 57,560 K while annual income is -44,140 K. The company’s previous quarter sales were 11,870 K while its latest quarter income was -17,060 K.
